Tonutti, E., Agostinis, P., & Bizzaro, N. (2014). Inflammatory bowel diseases: where we are and where we should go. Clinical Chemistry and Laboratory Medicine, 52(4), 463–465.
Article CAS PubMed Google Scholar
Wright, E. K., Ding, N. S., & Niewiadomski, O. (2018). Management of inflammatory bowel disease. Medical Journal of Australia, 209(7), 318–323.
Seyedian, S. S., Nokhostin, F., & Malamir, M. D. (2019). A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. The Journal of Medicine, 12(2), 113–122.
Rosen, M. J., Dhawan, A., & Saeed, S. A. (2015). Inflammatory Bowel Disease in Children and Adolescents. JAMA Pediatrics, 169(11), 1053–60.
Article PubMed PubMed Central Google Scholar
Mentella, M. C., Scaldaferri, F., Pizzoferrato, M., Gasbarrini, A., & Miggiano, G. A. D. (2020). Nutrition, IBD and Gut Microbiota: A Review. Nutrients, 12(4), 944.
Kelsen, J. R., Russo, P., & Sullivan, K. E. (2019). Early-Onset Inflammatory Bowel Disease. Immunology and Allergy Clinics of North America, 39(1), 63–79.
Article PubMed PubMed Central Google Scholar
Maldonado-Contreras, A. (2022). Food as Treatment of Inflammatory Bowel Diseases. Infection and Immunity, 90(5), e0058321.
Hodson, R. (2016). Inflammatory bowel disease. Nature, 540(7634), S97.
Article CAS PubMed Google Scholar
Singh, R., Rossini, V., Stockdale, S. R., Saiz-Gonzalo, G., Hanrahan, N., T, D. S., Clooney, A., et al. (2023). An IBD-associated pathobiont synergises with NSAID to promote colitis which is blocked by NLRP3 inflammasome and Caspase-8 inhibitors. Gut Microbes, 15(1), 2163838.
Article PubMed PubMed Central Google Scholar
Zhen, Y., & Zhang, H. (2019). NLRP3 Inflammasome and Inflammatory Bowel Disease. Frontiers in Immunology, 10, 276.
Article CAS PubMed PubMed Central Google Scholar
Larabi, A., Barnich, N., & Nguyen, H. T. T. (2020). New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD. Autophagy, 16(1), 38–51.
Article CAS PubMed Google Scholar
Liu, X., Fang, Y., Lv, X., Hu, C., Chen, G., Zhang, L., Jin, B., et al. (2023). Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3. Cell Death and Differentiation, 30(6), 1457–1471.
Article CAS PubMed PubMed Central Google Scholar
Cosin-Roger, J., Simmen, S., Melhem, H., Atrott, K., Frey-Wagner, I., Hausmann, M., de Vallière, C., et al. (2017). Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation. Nature Communications, 8(1), 98.
Article PubMed PubMed Central Google Scholar
He, X. F., Li, L. L., Xian, W. B., Li, M. Y., Zhang, L. Y., Xu, J. H., Pei, Z., et al. (2021). Chronic colitis exacerbates NLRP3-dependent neuroinflammation and cognitive impairment in middle-aged brain. Journal of Neuroinflammation, 18(1), 153.
Article CAS PubMed PubMed Central Google Scholar
Wang, W., Yang, N., Yang, Y.-H., Wen, R., Liu, C.-F., & Zhang, T.-N. (2021). Non-coding RNAs: Master regulators of inflammasomes in inflammatory diseases. Journal of Inflammation Research, 14, 5023–5050.
Wang, W., Yang, N., Yang, Y. H., Wen, R., Liu, C. F., & Zhang, T. N. (2021). Non-Coding RNAs: Master Regulators of Inflammasomes in Inflammatory Diseases. Journal of Inflammation Research, 14, 5023–5050.
Article PubMed PubMed Central Google Scholar
Fabián, O., & Kamaradová, K. (2022). Morphology of inflammatory bowel diseases (IBD). Cesk Patol, 58(1), 27–37.
Faye, A. S., & Colombel, J. F. (2022). Aging and IBD: A New Challenge for Clinicians and Researchers. Inflammatory Bowel Disease, 28(1), 126–132.
Wu, G., Zhang, D., Yang, L., Wu, Q., & Yuan, L. (2022). MicroRNA-200c-5p targets NIMA Related Kinase 7 (NEK7) to inhibit NOD-like receptor 3 (NLRP3) inflammasome activation, MODE-K cell pyroptosis, and inflammatory bowel disease in mice. Molecular Immunology, 146, 57–68.
Article CAS PubMed Google Scholar
Yue, C., Yang, X., Li, J., Chen, X., Zhao, X., Chen, Y., & Wen, Y. (2017). Trimethylamine N-oxide prime NLRP3 inflammasome via inhibiting ATG16L1-induced autophagy in colonic epithelial cells. Biochemical and Biophysical Research Communications, 490(2), 541–551.
Article CAS PubMed Google Scholar
Soutschek, M., & Schratt, G. (2023). Non-coding RNA in the wiring and remodeling of neural circuits. Neuron, 111(14), 2140–2154.
Article CAS PubMed Google Scholar
Panni, S., Lovering, R. C., Porras, P., & Orchard, S. (2020). Non-coding RNA regulatory networks. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms, 1863(6), 194417.
Article CAS PubMed Google Scholar
Samoilă, I., Dinescu, S., & Costache, M. (2020). Interplay between Cellular and Molecular Mechanisms Underlying Inflammatory Bowel Diseases Development-A Focus on Ulcerative Colitis. Cells, 9(7), 1647.
Scalavino, V., Piccinno, E., Valentini, A. M., Schena, N., Armentano, R., Giannelli, G., & Serino, G. (2023). miR-369-3p Modulates Intestinal Inflammatory Response via BRCC3/NLRP3 Inflammasome Axis. Cells, 12(17), 2184.
Varghese, G. P., Uporova, L., Halfvarson, J., Sirsjö, A., & Fransén, K. (2015). Polymorphism in the NLRP3 inflammasome-associated EIF2AK2 gene and inflammatory bowel disease. Molecular Medicine Reports, 11(6), 4579–4584.
Article CAS PubMed Google Scholar
Huang, M., Wang, Q., Long, F., Di, Y., Wang, J., Zhun Zhu, Y., & Liu, X. (2020). Jmjd3 regulates inflammasome activation and aggravates DSS-induced colitis in mice. The FASEB Journal, 34(3), 4107–4119.
Article CAS PubMed Google Scholar
Neudecker, V., Haneklaus, M., Jensen, O., Khailova, L., Masterson, J. C., Tye, H., Biette, K., et al. (2017). Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. Journal of Experimental Medicine, 214(6), 1737–1752.
Article CAS PubMed PubMed Central Google Scholar
Pan, Y., Wang, D., & Liu, F. (2022). miR-146b suppresses LPS-induced M1 macrophage polarization via inhibiting the FGL2-activated NF-κB/MAPK signaling pathway in inflammatory bowel disease. Clinics (Sao Paulo), 77, 100069.
Cai, X., Zhang, Z. Y., Yuan, J. T., Ocansey, D. K. W., Tu, Q., Zhang, X., Qian, H., et al. (2021). hucMSC-derived exosomes attenuate colitis by regulating macrophage pyroptosis via the miR-378a-5p/NLRP3 axis. Stem Cell Research and Therapy, 12(1), 416.
Article CAS PubMed PubMed Central Google Scholar
Pelia, R., Venkateswaran, S., Matthews, J. D., Haberman, Y., Cutler, D. J., Hyams, J. S., Denson, L. A., et al. (2021). Profiling non-coding RNA levels with clinical classifiers in pediatric Crohn’s disease. BMC Medical Genomics, 14(1), 194.
Article CAS PubMed PubMed Central Google Scholar
Triantaphyllopoulos, K. A. (2023). Long Non-Coding RNAs and Their “Discrete” Contribution to IBD and Johne’s Disease-What Stands out in the Current Picture? A Comprehensive Review. International Journal of Molecular Sciences, 24(17), 13566.
Ma, H., Hu, T., Tao, W., Tong, J., Han, Z., Herndler-Brandstetter, D., Wei, Z., et al. (2023). A lncRNA from an inflammatory bowel disease risk locus maintains intestinal host-commensal homeostasis. Cell Research, 33(5), 372–388.
Article CAS PubMed PubMed Central Google Scholar
Hu, Y., Lu, Y., Fang, Y., Zhang, Q., Zheng, Z., Zheng, X., Ye, X., et al. (2024). Role of long non-coding RNA in inflammatory bowel disease. Frontiers in Immunology, 15, 1406538.
Article CAS PubMed PubMed Central Google Scholar
Lucafò, M., Pugnetti, L., Bramuzzo, M., Curci, D., Di Silvestre, A., Marcuzzi, A., Bergamo, A., et al. (2019). Long Non-Coding RNA GAS5 and Intestinal MMP2 and MMP9 Expression: A Translational Study in Pediatric Patients with IBD. International Journal of Molecular Sciences, 20(21), 5280.
Hooftman, A., Angiari, S., Hester, S., Corcoran, S. E., Runtsch, M. C., Ling, C., Ruzek, M. C., et al. (2020). The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation. Cell Metabolism, 32(3), 468–78.e7.
Article CAS PubMed PubMed Central Google Scholar
Paik, S., Kim, J. K., Silwal, P., Sasakawa, C., & Jo, E. K. (2021). An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cellular and Molecular Immunology, 18(5), 1141–1160.
Comments (0)